4 completed. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
Follow Asperger Syndrome: new trials by email Literature Review of Asperger Syndrome trials Research Report on Asperger Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders Placebo, Mirtazapine - Autism Spectrum Disorders | Phase 3 | Completed | Massachusetts General Hospital | 30 | 2010-08-01 | 2018-11-07 |
| Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders Cognitive-behavioral therapy, Treatment as Usual - Autism, Asperger's Syndrome | Phase 2 / Phase 3 | Completed | University of South Florida | 45 | 2010-04-01 | 2013-04-02 |
| D-Cycloserine and Social Skills Training in Autism Spectrum Disorders D-cycloserine, Placebo - Autistic Disorder, Asperger's Disorder | Phase 3 | Completed | Indiana University | 68 | 2010-03-01 | 2016-04-14 |
| A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD) risperidone - DCild Development Disorders, Pervasive, Autistic Disorder | Phase 3 | Completed | Janssen-Ortho Inc., Canada | 80 | 1999-08-01 | 2011-01-24 |
Autistic Disorder (4) · Child Development Disorders, Pervasive (3) · Autism Spectrum Disorder (2) · Anxiety Disorders (1) · Anxiety, Separation (1) · Developmental Disabilities (1) · Generalized Anxiety Disorder (1) · Obsessive-Compulsive Disorder (1) · Phobia, Social (1) · Rett Syndrome (1)
Mental Disorders (4) · Neurodevelopmental Disorders (4) · Autism Spectrum Disorder (2) · Child Development Disorders, Pervasive (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Genetic Diseases, X-Linked (1) · Heredodegenerative Disorders, Nervous System (1) · Intellectual Disability (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · Phobic Disorders (1) · X-Linked Intellectual Disability (1)
Sugars (2) · Cognitive Behavioral Therapy (1) · Counseling (1) · Cycloserine (1) · Mirtazapine (1) · Psychotherapy (1) · Risperidone (1) · Therapeutics (1)
Indiana University (1) · Janssen-Ortho Inc., Canada (1) · Massachusetts General Hospital (1) · University of South Florida (1)
United States (3)
Christopher J. McDougle, M.D. (1) · Craig A. Erickson, M.D. (1) · Eric A Storch, Ph.D. (1) · Noha F. Minshawi, Ph.D. (1)
PMID 15492353, PMID 23357440, PMID 26770664, PMID 28138381, PMID 33583058, PMID 35241779, PMID 37811711